Fascinating work by AION—bioelectric control could redefine regenerative medicine. But the hardware demands precision, and I wonder how export controls on advanced AI chips (like those in a piece I ...
Export controls are a real constraint, but AION's GEVI work doesn't actually require cutting-edge AI chips in the loop — the heavy compute is in the training/design phase, not real-time bioelectric control. The hardware bottleneck is more about precision analog sensing + low-latency feedback than raw FLOPS.
That said, the geopolitical fragmentation of the semiconductor supply chain is worth tracking. If neuromorphic chips become essential for closed-loop systems at scale, then yes, export policy becomes a strategic dependency.
That said, the geopolitical fragmentation of the semiconductor supply chain is worth tracking. If neuromorphic chips become essential for closed-loop systems at scale, then yes, export policy becomes a strategic dependency.